Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05183932 · ClinicalTrials.gov registry record
Surgery Versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer
A clinical trial of Non-Small Cell Lung Cancer, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- 444
- Enrollment target
- 8
- Study locations
NCT05183932: Recruiting study of Non-Small Cell Lung Cancer, sponsored by Washington University School of Medicine.
NCT05183932 is a study of Non-Small Cell Lung Cancer that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 444 participants, below the 651-participant average among 454 other Non-Small Cell Lung Cancer trials with a reported enrollment target (32% lower). The trial reports 8 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05183932, a study of Non-Small Cell Lung Cancer, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- 444 participants
- Enrollment target
- 8
- Study locations
Study Summary
The development of stereotactic body radiation therapy (SBRT) for the treatment of stage I non-small cell lung cancer (NSCLC) has inspired a close partnership between thoracic surgery and radiation oncology. In this study, patients with stage I NSCLC will be screened prior to treatment and will be consented after their treatment plan has been determined. Prospectively collected patient-reported outcomes (PROs) will be collected for 3 years or for the duration of the study (whichever is shorter), as will outcomes data.
Primary Outcome
DFS is defined as time from the date of treatment to date of disease recurrence or death, whichever occurs earlier.
Conditions Studied
Study Locations (8)
Georgia
- Emory University - Atlanta
Illinois
- Carle Cancer Institute - Urbana
Missouri
- Washington University School of Medicine - St Louis
New York
- Memorial Sloan Kettering - New York
North Carolina
- Duke University - Durham
Ohio
- Cleveland Clinic - Cleveland
Texas
- University of Texas MD Anderson Cancer Center - Houston
Ontario
- University of Toronto - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 444 participants |
| Start Date | 2022-07-14 |
| Est. Completion | 2029-01-31 |
What NCT05183932 shows while recruiting
NCT05183932 is an observational study that tracks outcomes without assigning an intervention. The registered 444 participants enrollment target is mid-sized for trials with a published cap, below the 651-participant average among 454 other Non-Small Cell Lung Cancer trials with a reported enrollment target (32% lower).
The record links to 1 condition, with Non-Small Cell Lung Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT05183932 lists 8 locations in 8 states (Georgia, Illinois, Missouri).
Frequently Asked Questions
What is clinical trial NCT05183932 about?
NCT05183932 is a clinical study titled "Surgery Versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer". The development of stereotactic body radiation therapy (SBRT) for the treatment of stage I non-small cell lung cancer (NSCLC) has inspired a close partnership between thoracic surgery and radiation oncology. In this study, patients with stage I NSCLC will be screened prior to treatment and will be c...
What is the current status of trial NCT05183932?
This trial is currently recruiting. The enrollment target is 444 participants. The study started on 2022-07-14. Estimated completion is 2029-01-31.
What conditions does trial NCT05183932 study?
This clinical trial studies the following conditions: Non-Small Cell Lung Cancer.
Who is sponsoring clinical trial NCT05183932?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05183932 being conducted?
This trial has 8 study locations across Georgia, Illinois, Missouri, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-Small Cell Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05183932's enrollment target sits among peer trials
444 90th of 454 higher than 365 of 454 other Non-Small Cell Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Non-Small Cell Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RECRUITING · Phase 3
-
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RECRUITING · Phase 1
-
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
RECRUITING · Phase 1
-
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
RECRUITING · Phase 1
-
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06348394 · 444 participants · NA
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion
- NCT06700343 · 444 participants · Phase 3
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- NCT03504800 · 445 participants
OCT in Diagnosis of Irregular Corneas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI